{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:49:33Z","timestamp":1782168573623,"version":"3.54.5"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140601","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T14:09:03Z","timestamp":1445350143000},"page":"e0140601","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial"],"prefix":"10.1371","volume":"10","author":[{"given":"Francesco","family":"Oddone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Berardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ferrazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuele","family":"Michelessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Centofanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","article-title":"Treatment of ocular hypertension and open angle Glaucoma: meta-analysis of randomised controlled trials","volume":"331","author":"PC Maier","year":"2005","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for Glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial","volume":"121","author":"MC Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"Advanced Glaucoma Intervention Study. 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"AM J Ophthalmol"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archopht.126.8.1030","article-title":"Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma","volume":"126","author":"BC Chauhan","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"ref5","article-title":"CG85 Glaucoma","year":"2009"},{"key":"ref6","unstructured":"Terminology and Guidelines for Glaucoma 4th edition. European Glaucoma Society. Publicomm s.r.l. 2014."},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9394(99)00160-9","article-title":"Beta-blocker eyedrops and nocturnal arterial hypotension","volume":"128","author":"SS Hayreh","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0002-9394(14)70172-2","article-title":"Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group","volume":"123","author":"PA Netland","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ophtha.2007.10.004","article-title":"Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines","volume":"115","author":"WC Stewart","year":"2008","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","article-title":"Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials","volume":"112","author":"R Van der Valk","year":"2005","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajo.2009.12.003","article-title":"Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension","volume":"149","author":"LG Katz","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"ref12","first-page":"2912","article-title":"Twenty-four-hour pattern of intraocular pressure in the aging population","volume":"40","author":"JH Liu","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"ref13","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.survophthal.2003.12.017","article-title":"24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial","volume":"49","author":"TR Walters","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"ref14","first-page":"2566","article-title":"Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension","volume":"41","author":"N Orzalesi","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1167\/iovs.05-1253","article-title":"Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma","volume":"47","author":"L Quaranta","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9394(99)00073-2","article-title":"Comparison of 24-hour intraocular pressure reduction with dosing regimens of Latanoprost and timolol maleate in patients with primary open-angle glaucoma","volume":"128","author":"AG Konstas","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajo.2004.04.022","article-title":"Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure","volume":"138","author":"JH Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"ref18","first-page":"1","article-title":"Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure","volume":"2","author":"JD Tung","year":"2012","journal-title":"BMJ Open"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archophthalmol.2011.2573","article-title":"Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy","volume":"130","author":"V Gulati","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/112067211002000602","article-title":"Meta-analysis of timolol on diurnal and nighttime intraocular pressure and blood pressure","volume":"20","author":"PW Lee","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0039-6257(99)00016-8","article-title":"Nocturnal hypotension: role in glaucoma progression","volume":"43","author":"SL Graham","year":"1999","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0161-6420(00)00138-X","article-title":"Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study","volume":"107","author":"L Bonomi","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2010.01.018","article-title":"Blood Flow in Glaucoma Discussion. Blood pressure, perfusion pressure, and glaucoma","volume":"149","author":"J Caprioli","year":"2010","journal-title":"Am J Ophthalmol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T15:01:54Z","timestamp":1567263714000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140601"}},"subtitle":[],"editor":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140601","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}